IMMUNITYBIO, INC. (IBRX) Return on equity 2016–2019
IMMUNITYBIO, INC. (IBRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-966.4%FY2019 · since FY2016: -41.2% → -966.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | -966.4% | -849.0 pp |
| FY2018 | -117.4% | -73.4 pp |
| FY2017 | -44.1% | -2.9 pp |
| FY2016 | -41.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice